Impact of natural compounds on neurodegenerative disorders: From preclinical to pharmacotherapeutics
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://hdl.handle.net/10216/145264 |
Resumo: | Among the major neurodegenerative disorders (NDDs), Alzheimer’s disease (AD) and Parkinson’s disease (PD), are a huge socioeconomic burden. Over many centuries, people have sought a cure for NDDs from the natural herbals. Many medicinal plants and their secondary metabolites are reported with the ability to alleviate the symptoms of NDDs. The major mechanisms identified, through which phytochemicals exert their neuroprotective effects and potential maintenance of neurological health in ageing, include antioxidant, anti-inflammatory, antithrombotic, antiapoptotic, acetylcholinesterase and monoamine oxidase inhibition and neurotrophic activities. This article review the mechanisms of action of some of the major herbal products with potential in the treatment of NDDs according to their molecular targets, as well as their regional sources (Asia, America and Africa). A number of studies demonstrated the beneficial properties of plant extracts or their bioactive compounds against NDDs. Herbal products may potentially offer new treatment options for patients with NDDs, which is a cheaper and culturally suitable alternative to conventional therapies for millions of people in the world with age-related NDDs. |
id |
RCAP_aff45c4443a03078f052978387b6f0dd |
---|---|
oai_identifier_str |
oai:repositorio-aberto.up.pt:10216/145264 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Impact of natural compounds on neurodegenerative disorders: From preclinical to pharmacotherapeuticsAlzheimer’s diseaseDementiasNatural compoundsNeurodegenerative disordersParkinson’s diseasePharmacological activitiesPlants secondary metabolitesAmong the major neurodegenerative disorders (NDDs), Alzheimer’s disease (AD) and Parkinson’s disease (PD), are a huge socioeconomic burden. Over many centuries, people have sought a cure for NDDs from the natural herbals. Many medicinal plants and their secondary metabolites are reported with the ability to alleviate the symptoms of NDDs. The major mechanisms identified, through which phytochemicals exert their neuroprotective effects and potential maintenance of neurological health in ageing, include antioxidant, anti-inflammatory, antithrombotic, antiapoptotic, acetylcholinesterase and monoamine oxidase inhibition and neurotrophic activities. This article review the mechanisms of action of some of the major herbal products with potential in the treatment of NDDs according to their molecular targets, as well as their regional sources (Asia, America and Africa). A number of studies demonstrated the beneficial properties of plant extracts or their bioactive compounds against NDDs. Herbal products may potentially offer new treatment options for patients with NDDs, which is a cheaper and culturally suitable alternative to conventional therapies for millions of people in the world with age-related NDDs.MDPI20202020-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10216/145264eng2077-038310.3390/jcm9041061Sharifi-Rad, MLankatillake, CDias, DADocea, AOMahomoodally, MFLobine, DChazot, PLKurt, BTumer, TBMoreira, ACSharopov, FMartorell, MMartins, NCho, WCCalina, DSharifi-Rad, Jinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-29T16:14:11Zoai:repositorio-aberto.up.pt:10216/145264Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T00:39:34.779469Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Impact of natural compounds on neurodegenerative disorders: From preclinical to pharmacotherapeutics |
title |
Impact of natural compounds on neurodegenerative disorders: From preclinical to pharmacotherapeutics |
spellingShingle |
Impact of natural compounds on neurodegenerative disorders: From preclinical to pharmacotherapeutics Sharifi-Rad, M Alzheimer’s disease Dementias Natural compounds Neurodegenerative disorders Parkinson’s disease Pharmacological activities Plants secondary metabolites |
title_short |
Impact of natural compounds on neurodegenerative disorders: From preclinical to pharmacotherapeutics |
title_full |
Impact of natural compounds on neurodegenerative disorders: From preclinical to pharmacotherapeutics |
title_fullStr |
Impact of natural compounds on neurodegenerative disorders: From preclinical to pharmacotherapeutics |
title_full_unstemmed |
Impact of natural compounds on neurodegenerative disorders: From preclinical to pharmacotherapeutics |
title_sort |
Impact of natural compounds on neurodegenerative disorders: From preclinical to pharmacotherapeutics |
author |
Sharifi-Rad, M |
author_facet |
Sharifi-Rad, M Lankatillake, C Dias, DA Docea, AO Mahomoodally, MF Lobine, D Chazot, PL Kurt, B Tumer, TB Moreira, AC Sharopov, F Martorell, M Martins, N Cho, WC Calina, D Sharifi-Rad, J |
author_role |
author |
author2 |
Lankatillake, C Dias, DA Docea, AO Mahomoodally, MF Lobine, D Chazot, PL Kurt, B Tumer, TB Moreira, AC Sharopov, F Martorell, M Martins, N Cho, WC Calina, D Sharifi-Rad, J |
author2_role |
author author author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Sharifi-Rad, M Lankatillake, C Dias, DA Docea, AO Mahomoodally, MF Lobine, D Chazot, PL Kurt, B Tumer, TB Moreira, AC Sharopov, F Martorell, M Martins, N Cho, WC Calina, D Sharifi-Rad, J |
dc.subject.por.fl_str_mv |
Alzheimer’s disease Dementias Natural compounds Neurodegenerative disorders Parkinson’s disease Pharmacological activities Plants secondary metabolites |
topic |
Alzheimer’s disease Dementias Natural compounds Neurodegenerative disorders Parkinson’s disease Pharmacological activities Plants secondary metabolites |
description |
Among the major neurodegenerative disorders (NDDs), Alzheimer’s disease (AD) and Parkinson’s disease (PD), are a huge socioeconomic burden. Over many centuries, people have sought a cure for NDDs from the natural herbals. Many medicinal plants and their secondary metabolites are reported with the ability to alleviate the symptoms of NDDs. The major mechanisms identified, through which phytochemicals exert their neuroprotective effects and potential maintenance of neurological health in ageing, include antioxidant, anti-inflammatory, antithrombotic, antiapoptotic, acetylcholinesterase and monoamine oxidase inhibition and neurotrophic activities. This article review the mechanisms of action of some of the major herbal products with potential in the treatment of NDDs according to their molecular targets, as well as their regional sources (Asia, America and Africa). A number of studies demonstrated the beneficial properties of plant extracts or their bioactive compounds against NDDs. Herbal products may potentially offer new treatment options for patients with NDDs, which is a cheaper and culturally suitable alternative to conventional therapies for millions of people in the world with age-related NDDs. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020 2020-01-01T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://hdl.handle.net/10216/145264 |
url |
https://hdl.handle.net/10216/145264 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
2077-0383 10.3390/jcm9041061 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
MDPI |
publisher.none.fl_str_mv |
MDPI |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799136301858947072 |